F. NO. 8 (22)/99/DP/NPPA-Div.II
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY
NEW DELHI, DATED THE 28/12/1999
ORDER
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 and paragraph 11 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (7) of the Table hereto annexed as the retail price/revised retail price, exclusive of local tax if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof:
Sl. No. | Name of the formulation | Pack Size | Existing Retail Price | Retail Price without Excise Duty (Rs.) | ExciseDuty (Rs.) | Revised Retail Price with Excise Duty (Rs.) |
---|---|---|---|---|---|---|
(1) | (2) | (3) | (4) | (5) | (6) | (7) |
1. | Wysolone Tab. 5mg Each tab contains Prednisolone – 5mg |
10’s GPBL |
6.03 | 6.78 | 0.85 | 7.63 |
2. | Wysolone Tab. 10mg Each tab contains Prednisolone – 10mg |
10’s GPST |
11.62 | 13.10 | 1.62 | 14.72 |
3. | Wysolone Tab. 20mg Each tab contains Prednisolone – 20mg |
6’s Al_St |
13.65 | 15.48 | 1.92 | 17.40 |
2. This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of
a. the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and
b. the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.
3. These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
4. The prices given in Column 7 of the above table will remain valid subject to the condition that the company captively consumes the bulk drug Prednisolone produced by them and the company is required to submit the return by 10th of January, April, July and October of its preceding quarter to the Govt./NPPA regarding in-house production and consumption as well as procurement from other sources including imports of bulk drug Prednisolone.
PN/31/99/F
M/s. WYETH LEDERLE LTD.
Nyloc House
254 D-2, Dr. Annie Besant Road,
P.O. Box No. 9109 Worli,
Mumbai-400025
(S. K. BHATT)
Dy. Director
Last Page Updated: 16-01-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)